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Background/Purpose: BRCA1/2 mutation carriers possess an elevated lifetime risk 
for hereditary breast and ovarian cancer (HBOC), yet the availability of risk assessment 
and genetic testing for HBOC in Asians is far limited, thus limiting the chances for ap-
propriate surveillance, clinical strategies and cancer management. 
Methods: Current status of HBOC management in 14 Asian countries was reviewed. 
Data of genetic counseling and genetic testing uptake rates were collected, and were an-
alyzed how economic factors, healthcare system, legal frameworks and cultural issues 
affect the genetic service availability in Asia. 
Results: It was estimated that in 2012, of the 560,000 breast cancer patients in 14 Asian 
countries, only around 4,000 individuals were benefited from genetic counseling and 
3,200 were tested, in which over 40% of the cases were from Korea. Economic factors 
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such as genetic service costs, and the lack of adoption into national healthcare systems 
(with the exception of Korea) are major barriers to genetic risk assessment in Asian 
countries. In addition, regional accredited laboratories, training programmes, and 
trained healthcare professionals are readily available only in half of the studied coun-
tries. 
Conclusion: These limitations in healthcare system, combined with the lack of legal 
frameworks against genetic discrimination and lack of awareness among general 
public, remain the main challenges to HBOC management in Asia. The Asian BRCA 
(ABRCA) Consortium reports the current limitations in genetic counseling and testing 
for familial breast cancer in Asia, and urges the governments, healthcare sectors and 
researchers to address the disparities in HBOC management. 
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